Ertapenem Sodium Patent Expiration
Ertapenem Sodium is Used for treating bacterial infectious diseases. It was first introduced by Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc
Ertapenem Sodium Patents
Given below is the list of patents protecting Ertapenem Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Invanz |
US5952323 (Pediatric) | Carbapenem antibiotic |
Nov 15, 2017
(Expired) | Msd Sub Merck |
| Invanz | US5952323 | Carbapenem antibiotic |
May 15, 2017
(Expired) | Msd Sub Merck |
| Invanz |
US5478820 (Pediatric) | Antibiotic compounds |
May 21, 2016
(Expired) | Msd Sub Merck |
| Invanz | US5478820 | Antibiotic compounds |
Nov 21, 2015
(Expired) | Msd Sub Merck |
| Invanz |
US5652233 (Pediatric) | Antibiotic compounds |
Aug 02, 2013
(Expired) | Msd Sub Merck |
| Invanz |
US7342005 (Pediatric) | Antibiotic compounds |
Aug 02, 2013
(Expired) | Msd Sub Merck |
| Invanz | US5652233 | Antibiotic compounds |
Feb 02, 2013
(Expired) | Msd Sub Merck |
| Invanz | US7342005 | Antibiotic compounds |
Feb 02, 2013
(Expired) | Msd Sub Merck |
Ertapenem Sodium's Family Patents
Explore Our Curated Drug Screens
Ertapenem Sodium Generic API Manufacturers
Several generic applications have been filed for Ertapenem Sodium. The first generic version for Ertapenem Sodium was by Acs Dobfar Spa and was approved on Apr 16, 2018. And the latest generic version is by Qilu Pharmaceutical Co Ltd and was approved on Oct 31, 2024.
Given below is the list of companies who have filed for Ertapenem Sodium generic, along with the locations of their manufacturing plants worldwide.
1. ACS DOBFAR SPA
Acs Dobfar Spa has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Acs Dobfar Spa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Prescription | INTRAMUSCULAR, INTRAVENOUS | AP | Apr 16, 2018 |
Manufacturing Plant Locations New
Acs Dobfar Spa's manufacturing plants are situated in 1 country - Italy. Given below are the details of these plant locations as well as the firm names of Acs Dobfar Spa as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Italy |
| |||||||
2. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Prescription | INTRAMUSCULAR, INTRAVENOUS | AP | Jun 25, 2018 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
3. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Prescription | INTRAMUSCULAR, INTRAVENOUS | AP | Mar 26, 2021 |
4. QILU
Qilu Pharmaceutical Co Ltd has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Qilu.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Prescription | INTRAMUSCULAR, INTRAVENOUS | AP | Oct 31, 2024 |
Manufacturing Plant Locations New
Qilu's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Qilu as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China |
| |||||||||||||||
5. SAVIOR LIFETEC CORP
Savior Lifetec Corp has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Savior Lifetec Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Prescription | INTRAMUSCULAR, INTRAVENOUS | AP | Mar 19, 2019 |
Manufacturing Plant Locations New
Savior Lifetec Corp's manufacturing plants are situated in 1 country - Taiwan. Given below are the details of these plant locations as well as the firm names of Savior Lifetec Corp as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Taiwan |
| |||||||
6. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Discontinued | INTRAMUSCULAR, INTRAVENOUS | N/A | May 2, 2023 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||